Phase I Trial of the Cyclin-Dependent Kinase Inhibitor Flavopiridol in Combination with Docetaxel in Patients with Metastatic Breast Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase I Trial of the Cyclin-Dependent Kinase Inhibitor Flavopiridol in Combination with Docetaxel in Patients with Metastatic Breast Cancer

Published:2004-08-01 Issue:15 Volume:10 Page:5038-5047
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Tan Antoinette R.,Yang Xiaowei,Berman Arlene,Zhai Suoping,Sparreboom Alex,Parr Allyson L.,Chow Catherine,Brahim Jaime S.,Steinberg Seth M.,Figg William D.,Swain Sandra M.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Seize the engine: Emerging cell cycle targets in breast cancer;Clinical and Translational Medicine;2024-01

2. Marine-Derived Compounds for CDK5 Inhibition in Cancer: Integrating Multi-Stage Virtual Screening, MM/GBSA Analysis and Molecular Dynamics Investigations;Metabolites;2023-10-18

3. Novel Medicinal Chemistry Strategies Targeting CDK5 for Drug Discovery;Journal of Medicinal Chemistry;2023-05-26

4. Flavonoids for the Treatment of Breast Cancer, Present Status and Future Prospective;Anti-Cancer Agents in Medicinal Chemistry;2023-04

5. CDK inhibitors from past to present: A new wave of cancer therapy;Seminars in Cancer Biology;2023-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP